France’s Ipsen will get a manufacturing foothold in the U.S. with a new deal to expand its oncology reach in the country.

India’s Aurobindo Pharma, which has been building its presence around the world, has struck a new deal to buy a generics manufacturer and plant in Portugal…

Swiss CMO Lonza, which has been searching for a game-changing M&A deal, looks to have unearthed one in contractor Capsugel.

Sanofi recently that it will sell off its generic drug unit in Europe, a decision that will affect two manufacturing plants in the Czech Republic and Romania.

Investors knew that Pfizer’s $14 billion acquisition of Medivation and its prostate cancer drug Xtandi would immediately boost the pharma giant’s earnings, but…

A brand-new contract development and manufacturing organization has broken onto the scene, U.K.-based Sterling Pharma Solutions, which was created from a…

Abbott picked up Vietnamese drug manufacturer Glomed for an undisclosed price in a deal that gives the pharma giant two manufacturing facilities in that…

Two of the world’s largest generics makers are looking to lay their hands on the largest generics manufacturing plant in Latin America, sources tell Reuters,…

Since it bought out Ranbaxy Laboratories last year, Sun Pharma has been in the process of trimming back its manufacturing network of nearly 50 plants to a more…

M&A